Skip to main navigation Skip to search Skip to main content

MT2020-36: A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of AutologousTumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma

  • Domingo-Musibay, Evidio (PI)

Project: Research project

Project Details

Description

MT2020-36: A Phase 2, Open-label, Multicenter Study Evaluating the Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes (TILs) in Subjects with Advanced Melanoma
StatusFinished
Effective start/end date10/28/20 → 10/31/25

Funding

  • INSTIL BIO, INC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.